Author:
Witkin Jeffrey M.,Martin Anna E.,Golani Lalit K.,Xu Nina Z.,Smith Jodi L.
Reference241 articles.
1. Rapamycin, an immunosuppressant and mTORC1 inhibitor, triples the antidepressant response rate of ketamine at 2 weeks following treatment: A double-blind, placebo-controlled, cross-over, randomized clinical trial;Abdallah,2018
2. The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?;Abdallah;Pharmacology and Therapeutics,2018
3. NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys;Adams;Synapse,2002
4. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice;Ago;Neuropharmacology,2013
5. A role for AMPA receptors in mood disorders;Alt;Biochemical Pharmacology,2006
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献